This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Group Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Thomas Matthew Webb
Introduction
Thomas Matthew Webb is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. With a total of 2 patents to his name, Webb's work focuses on addressing critical health issues.
Latest Patents
Webb's latest patents include innovative CD127 binding proteins. These antigen binding proteins specifically target the human IL-7 receptor (CD127). They are primarily designed as antibodies and hold promise for treating various diseases or disorders in humans. Notably, they are particularly useful in combating autoimmune diseases such as multiple sclerosis.
Career Highlights
Webb is currently associated with Glaxo Group Limited, where he continues to advance his research and development efforts. His work has the potential to impact the treatment landscape for autoimmune conditions significantly.
Collaborations
Throughout his career, Webb has collaborated with esteemed colleagues, including Ian Kirby and Yu Xue. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Thomas Matthew Webb's contributions to the field of biotechnology through his patents and collaborations highlight his commitment to improving human health. His work on CD127 binding proteins exemplifies the potential of innovative solutions in treating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile